Fierce Healthcare August 6, 2024
Emma Beavins

The Food and Drug Administration has announced the technical experts and industry representatives that will take part in its new Digital Health Advisory Committee (DHAC). The committee will address the use of generative AI in medical devices at its first meeting in November.

FDA announced in October 2023 that it would create a digital health advisory committee to inform FDA on considerations for digital health technologies such as AI/ML, virtual reality, wearables, digital therapeutics and remote patient monitoring. DHAC will also weigh in on issues like decentralized clinical trials, patient-generated health data, real-world data, real-world evidence and cybersecurity, the FDA’s website says.

The FDA put out an open call for technical experts on digital health technologies to apply to sit...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article